Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma (TMI-ASCT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Ottawa Hospital Research Institute
Sponsor:
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00800059
First received: November 27, 2008
Last updated: July 23, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2025
  Estimated Primary Completion Date: November 2020 (Final data collection date for primary outcome measure)